Lanton Law Blog

Learn about the latest trends and activities through our blog posts.

Posts tagged Most-Favored-Nation (MFN) Pricing

Lanton Law Interviewed by Pharmacy Times Over Prescription Drug Price Executive Order

Lanton Law was quoted in Pharmacy Times’ article titled “President Trump Signs Executive Order Aiming to Lower Prescription Drug Costs by Up to 90%.”

healthcare, pharmaceuticals, pharmacy benefit manager, prescription drug costs, PhRMARon LantonMay 14, 2025prescription drug prices, Executive Order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, Most-Favored-Nation (MFN) Pricing, MFN, healthcare, prescription, pharmaceutical, drug manufacturer

Understanding the 2025 Executive Order on Most-Favored-Nation Drug Pricing: Implications for Healthcare Stakeholders

On May 12, 2025, President Trump signed an executive order titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients," aiming to align U.S. prescription drug prices with the lowest prices paid by other developed nations.

Ron LantonMay 13, 2025Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, Most-Favored-Nation (MFN) Pricing, Secretary of Commerce, U.S. Trade Representative, pharmaceuticals, tariffs, pharmaceutical tariffs